← Eichor
Study identifier: NCT07420101 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs

Condition: Caregiver Anxiety · Caregiver Anxiety Related to Cancer Imaging · Pediatric Oncology  ·  Sponsor: Kimberley Roche

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. The main purposes of this study are two-fold: 1). to determine if scanxiety exists in the caregivers of pediatric oncology patients and 2.) if scanxiety is found, does the implementation of a mindfulness program help to improve caregiver anxiety related to imaging.

This description comes directly from the study's public registry record.

Talk to the study team

Kimberley Roche, MSN, PPCNP-BC, APRN  ·  860-545-9671  ·  KRoche01@connecticutchildrens.org

Adam Barselau, MS  ·  860-545-9671  ·  Abarselau@connecticutchildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Connecticut Children's Medical CenterHartford, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07420101